morphine sulfate ER Avinza
Selected indexed studies
- A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. (J Opioid Manag, 2006) [PMID:17326594]
- Extended-release morphine sulfate in treatment of severe acute and chronic pain. (J Pain Res, 2010) [PMID:21197323]
- The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. (J Opioid Manag, 2006) [PMID:17319449]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial. (2006) pubmed
- Extended-release morphine sulfate in treatment of severe acute and chronic pain. (2010) pubmed
- The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain. (2006) pubmed
- A randomized, open-label, multicenter trial comparing once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: improved physical functioning in the ACTION trial. (2007) pubmed